ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

Cancer center investigators share Nobel Prizes in medicine, chemistry.

October 8, 2004

NCI Funds; Ad Hoc Group Approves NCCTG Renewal

September 18, 1981

Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws

November 20, 1992

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

May 14, 1976